DNA mismatch repair enzyme immunohistochemistry in colorectal cancer: a comparison of biopsy and resection material

References

• Odze RD, Goldblum JR. Surgical Pathology of the GI Tract, Liver, Biliary Tract and Pancreas. 2nd ed. Philadelphia: Saunders, 2008; 598–605.
   Google Scholar
• Brice P, editor. Biomarkers in Familial Colorectal Cancer Screening: Workshop Report and Recommendations. Cambridge: Public Health Genetics Unit, 2006.
   Google Scholar
• Shia J. Immunohistochemistry versus microsatellite instability testing for screening colorectal cancer patients at risk for hereditary nonpolyposis colorectal cancer syndrome: Part I. The utility of immunohistochemistry. J Mol Diagn 2008; 10: 293–300.
   PubMed Web of Science ®Google Scholar
• Boland CR, Thibodeau SN, Hamilton SR, et al A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: Development of International Criteria for the Determination of Microsatellite Instability in Colorectal Cancer. Cancer Res 1998; 58: 5248–5257.
   PubMed Web of Science ®Google Scholar
• Blanes A, Diaz-Cano SJ. Complementary analysis of microsatellite tumor profile and mismatch repair defects in colorectal carcinomas. World J Gastroenterol 2006; 12: 5932–5940.
   PubMedGoogle Scholar
• Chaves P CC, Lage P, Claro I, Cravo M, Leitão CN, Soares J. Immunohistochemical detection of mismatch repair gene proteins as a useful tool for the identification of colorectal carcinoma with the mutator phenotype. J Pathol 2000; 191: 355–360.
   PubMedGoogle Scholar
• Caldes T, Godino J, Sanchez A, et al Immunohistochemistry and microsatellite instability testing for selecting MLH1, MSH2 and MSH6 mutation carriers in hereditary non-polyposis colorectal cancer. Oncol Rep 2004; 12: 621–629.
   PubMedGoogle Scholar
• Ewald J, Rodrigue CM, Mourra N, et al Immunohistochemical staining for mismatch repair proteins, and its relevance in the diagnosis of hereditary non-polyposis colorectal cancer. Br J Surg 2007; 94: 1020–1027.
   PubMedGoogle Scholar
• de Jong AE, van Puijenbroek M, Hendriks Y, et al Microsatellite instability, immunohistochemistry, and additional PMS2 staining in suspected hereditary nonpolyposis colorectal cancer. Clin Cancer Res 2004; 10: 972–980.
   PubMed Web of Science ®Google Scholar
• Rigau V, Sebbagh N, Olschwang S, et al Microsatellite instability in colorectal carcinoma. The comparison of immunohistochemistry and molecular biology suggests a role for hMSH6 immunostaining. Arch Pathol Lab Med 2003; 127: 694–700.
   PubMedGoogle Scholar
• Pigatto F, Bateman A, Bunyan D, et al Economic and Practical Factors in Diagnosing HNPCC Using Clinical Criteria, Immunohistochemistry and Microsatellite Instability Analysis. Hered Cancer Clin Pract 2004; 2: 175–184.
   PubMedGoogle Scholar
• Goldberg Y, Porat R, Sagi M, et al A new oncogenetic service of counseling and diagnosing for hereditary non-polyposis colorectal cancer (HNPCC). (Hebrew.) Harefuah 2007; 146: 510–514, 76, 75.
   PubMedGoogle Scholar
• Lindor NM, Burgart LJ, Leontovich O, et al Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. J Clin Oncol 2002; 20: 1043–1048.
   PubMed Web of Science ®Google Scholar
• Shia J, Klimstra DS, Nafa K, et al Value of immunohistochemical detection of dna mismatch repair proteins in predicting germline mutation in hereditary colorectal neoplasms. Am J Surg Pathol 2005; 29: 96–104.
   PubMedGoogle Scholar
• Cunningham JM, Kim CY, Christensen ER, et al The frequency of hereditary defective mismatch repair in a prospective series of unselected colorectal carcinomas. Am J Hum Genet 2001; 69: 780–790.
   PubMed Web of Science ®Google Scholar
• Muller A, Giuffre G, Edmonston TB, et al Challenges and pitfalls in HNPCC screening by microsatellite analysis and immuno- histochemistry. J Mol Diagn 2004; 6: 308–315.
   PubMedGoogle Scholar
• Watson N, Grieu F, Morris M, et al Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer. J Mol Diagn 2007; 9: 472–478.
   PubMedGoogle Scholar
• Edmonston TB, Cuesta KH, Burkholder S, et al Colorectal carcinomas with high microsatellite instability: Defining a distinct immunologic and molecular entity with respect to prognostic markers. Hum Pathol 2000; 31: 1506–1514.
   PubMed Web of Science ®Google Scholar
• Ribic CM, Sargent DJ, Moore MJ, et al Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 2003; 349: 247–257.
   PubMed Web of Science ®Google Scholar
• University of Birmingham. FOxTROT: A Multi-Centre Randomised Controlled Trial Comparing Colorectal Cancer Recurrence With Neoadjuvant Chemotherapy Versus Post-Operative Chemotherapy. Birmingham: University of Birmingham, 2009.
   Google Scholar
• Samimi G, Fink D, Varki NM, et al Analysis of MLH1 and MSH2 expression in ovarian cancer before and after platinum drug-based chemotherapy. Clin Cancer Res 2000; 6: 1415–1421.
   PubMed Web of Science ®Google Scholar
• Di Nicolantonio F, Mercer S, Knight L, et al Cancer cell adaptation to chemotherapy. BMC Cancer 2005; 5: 78.
   PubMed Web of Science ®Google Scholar
• Royal College of Pathologists of Australasia (RCPA). Position Statement: Consent for Performing MSI and IHC Pre-screening for HNPCC. Sydney: RCPA Genetics Advisory Committee and Anatomical Pathology Advisory Committee, 2008.
   Google Scholar
• Arends MIM, Happerfield L, Frayling I, Miller K. Interpretation of immunohistochemical analysis of mismatch repair (mmr) protein expression in tissue sections for investigation of suspected Lynch/hereditary non-polyposis colorectal cancer (HNPCC) syndrome. UK NEQAS ICC & ISH Recommendations June 2008; Issue 1. Available at: http://www.cmgs.org/BPGs/pdfs%20current%20bpgs/hnpcc%20recommendations%20B.pdf (accessed May 2010).
   Google Scholar
• Altman DG. Practical Statistics for Medical Research. London: Chapman and Hall, 1991.
   Google Scholar
• Campbell MJ, Machin D. Medical Statistics. A Commonsense Approach. 3rd ed. Chichester: John Wiley & Sons, 1999.
   Google Scholar
• Boardman LA, Lanier AP, French AJ, et al Frequency of defective DNA mismatch repair in colorectal cancer among the Alaska Native people. Cancer Epidemiol Biomarkers Prev 2007; 16: 2344–2350.
   PubMed Web of Science ®Google Scholar
• Hameed F, Goldberg PA, Hall P, Algar U, van Wijk R, Ramesar R. Immunohistochemistry detects mismatch repair gene defects in colorectal cancer. Colorectal Dis 2006; 8: 411–417.
   PubMedGoogle Scholar
• Kohonen-Corish MR, Daniel JJ, Chan C, et al Low microsatellite instability is associated with poor prognosis in stage C colon cancer. J Clin Oncol 2005; 23: 2318–2324.
   PubMedGoogle Scholar
• Samowitz WS, Curtin K, Ma K-N, et al Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 2001; 10: 917–923.
   PubMed Web of Science ®Google Scholar
• Barnetson RA, Tenesa A, Farrington SM, et al Identification and survival of carriers of mutations in DNA mismatch-repair genes in colon cancer. N Engl J Med 2006; 354: 2751–2763.
   PubMed Web of Science ®Google Scholar
• Valle L, Perea J, Carbonell P, et al Clinicopathologic and pedigree differences in amsterdam I-positive hereditary nonpolyposis colorectal cancer families according to tumor microsatellite instability status. J Clin Oncol 2007; 25: 781–786.
   PubMedGoogle Scholar
• Jover R, Zapater P, Castells A, et al Mismatch repair status in the prediction of benefit from adjuvant fluorouracil chemotherapy in colorectal cancer. Gut 2006; 55: 848–855.
   PubMed Web of Science ®Google Scholar
• Alazzouzi H, Domingo E, Gonzalez S, et al Low levels of microsatellite instability characterize MLH1 and MSH2 HNPCC carriers before tumor diagnosis. Hum Mol Genet 2005; 14: 235–239.
   PubMedGoogle Scholar
• Halvarsson B, Lindblom A, Johansson L, Lagerstedt K, Nilbert M. Loss of mismatch repair protein immunostaining in colorectal adenomas from patients with hereditary nonpolyposis colorectal cancer. Mod Pathol 2005; 18: 1095–1101.
   PubMedGoogle Scholar
• World Health Organization (WHO). Cancer: Colorectal Cancer. Geneva: WHO, February 2009. Available at: http://www.who.int/cancer/en/ (accessed February 2009).
   Google Scholar
• Gebert J, Sun M, Ridder R, et al Molecular profiling of sporadic colorectal tumors by microsatellite analysis. Int J Oncol 2000; 16: 169–179.
   PubMedGoogle Scholar
• Jover R, Paya A, Alenda C, et al Defective mismatch-repair colorectal cancer: clinicopathologic characteristics and usefulness of immunohistochemical analysis for diagnosis. Am J Clin Pathol 2004; 122: 389–394.
   PubMedGoogle Scholar